Cesar B Rodriguez

US Patent:

20180177719, Jun 28, 2018

Filed:

Feb 21, 2016

Appl. No.:

15/507976

Inventors:

- Fort Worth TX, US
Cesar Rodriguez - Prosper TX, US
David Henzler - Haslet TX, US
Jeff Currington - Corinth TX, US
Megha Sharma - Lewisville TX, US
Daniel Aldrich - Bedford TX, US
Cameron Currington - Corinth TX, US
Michael Sloane - Fort Worth TX, US

International Classification:

A61K 9/00
A61K 47/14
A61K 31/4045
A61K 9/06
A61K 47/34
A61K 47/10
A61K 47/18
A61K 47/32
A61K 47/26
A61K 47/02
A61K 31/138
A61K 31/137
A61K 31/4402
A61K 31/485
A61K 31/167
A61K 31/09
B65D 75/36

Abstract:

By individually metering and dispensing specific volumes and/or weights of each component of a dosage, an amount of the components for each dose is secured with very high accuracy. A method for dosing a pharmaceutical product in a sealed container, such as, for example, a packet, sachet, blister pack, or other unit dose form. The dosage may include a first component that is a thickening agent and a second component that is an active ingredient. The thickening agent serves as a carrier that allows the active ingredient to dissolve in the mouth and be swallowed without the administration of water. The method includes providing the first component by measuring the volume or weighing the mass of the first component and measuring the volume or weighing the mass of the second component. Subsequent components may also be individually measured or weighed before being added to a package.

US Patent:

20160279058, Sep 29, 2016

Filed:

Mar 24, 2016

Appl. No.:

15/079852

Inventors:

Cesar Rodriguez - Fort Worth TX, US
David Henzler - Fort Worth TX, US
Megha Sharma - Fort Worth TX, US
Alan Jones - Fort Worth TX, US

International Classification:

A61K 9/06
A61K 47/46
A61K 47/42
A61K 45/06
A61K 31/355
A61K 31/4188
A61K 31/593
A61K 31/07
A61K 31/122
A61K 31/519
A61K 31/197
A61K 31/714
A61K 31/51
A61K 31/525
A61K 31/4415
A61K 31/455
A61K 9/00

Abstract:

A protein gel for encapsulation and controlled delivery of bioactive compounds is provided. These specific bioactive compounds may include but are not limited to vitamins, minerals, medications, probiotics and other bioactive supplements; and the amounts and/or dosages of the bioactive agents and ingredients may be adjusted to properly suit adults, children, or elderly dependent upon the end-use. This protein gel may act as both a pharmaceutical and nutraceutical, and may contain the active therapeutic compound, such as an antibiotic, chemotherapeutic, or pain medication in conjunction with specific nutrients that may act synergistically with the medication to enhance efficacy and overall health of the patient. The gel may be consumed alone or incorporated into food products such as cereal-type bars or mixed into biscuits, cookies, and the like.